Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Findings from J.W. Goodwin and co-researchers advance knowledge in breast cancer
May 22nd, 2008
" Prior progestin studies treating hot flashes in women have been short duration and single dose. This study tests the progestin megesterol acetate ( MA) at two doses versus placebo over 6 months," researchers in the United States report. "Patients and Methods Patients with T1-3, N0-1, M0 breast cancer were eligible after completion of surgery and chemotherapy and at least 4 months of tamoxifen ( if prescribed). Women were required to have at least 10 hot flashes of any severity or at least five severe episodes per week. Patients were randomly assigned to placebo, MA 20 mg, or MA 40 mg for 3 months. Success at 3 months was defined as completion of treatment with a>=...
Source: Women's Health Weekly (2008-05-22)
|
